Suppression of oncogene transcription - PNA as targeted cancer therapy for BRAF-V600E mutant melanoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2016-10, Vol.27, p.vi117-vi117
Hauptverfasser:	Rothman, J.H., Surriga, O., Ambrosini, G., Vasudeva, S., Schwartz, G.K.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	vi117
container_issue
container_start_page	vi117
container_title	Annals of oncology
container_volume	27
creator	Rothman, J.H. Surriga, O. Ambrosini, G. Vasudeva, S. Schwartz, G.K.
description
doi_str_mv	10.1093/annonc/mdw368.11
format	Article
fullrecord	<record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdw368_11</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419439987</els_id><sourcerecordid>S0923753419439987</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2741-da606000bbd1d1712149161374e3d075efced922800e8c6ae6ef09576cf634393</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0EEqWwZ-kfSDuOEydmV6oWkCpAvLaWa09KUGNHtgvq35OqbFnN4upc3TmEXDOYMJB8qp3zzkw7-8NFPWHshIxYKWRWQ8FOyQhkzrOq5MU5uYjxCwCEzOWI4Ouu7wPG2HpHfUOHDr9BhzQF7aIJbZ8OSUafH2dUR5p02GBCS412BgNNnxh0v6eND_T2ZbbMPgTAgna7pF2iHW61852-JGeN3ka8-rtj8r5cvM3vs9XT3cN8tspMXhUss1rAgMN6bZllFctZIZlgvCqQW6hKbAxamec1ANZGaBTYgCwrYRrBCy75mMCx1wQfY8BG9aHtdNgrBuqgSR01qaMmxdiA3BwRHHZ9txhUNC0Ov9k2oEnK-vZ_-BceyHH0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Suppression of oncogene transcription - PNA as targeted cancer therapy for BRAF-V600E mutant melanoma</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Rothman, J.H. ; Surriga, O. ; Ambrosini, G. ; Vasudeva, S. ; Schwartz, G.K.</creator><creatorcontrib>Rothman, J.H. ; Surriga, O. ; Ambrosini, G. ; Vasudeva, S. ; Schwartz, G.K.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdw368.11</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2016-10, Vol.27, p.vi117-vi117</ispartof><rights>2016 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Rothman, J.H.</creatorcontrib><creatorcontrib>Surriga, O.</creatorcontrib><creatorcontrib>Ambrosini, G.</creatorcontrib><creatorcontrib>Vasudeva, S.</creatorcontrib><creatorcontrib>Schwartz, G.K.</creatorcontrib><title>Suppression of oncogene transcription - PNA as targeted cancer therapy for BRAF-V600E mutant melanoma</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kMtOwzAQRS0EEqWwZ-kfSDuOEydmV6oWkCpAvLaWa09KUGNHtgvq35OqbFnN4upc3TmEXDOYMJB8qp3zzkw7-8NFPWHshIxYKWRWQ8FOyQhkzrOq5MU5uYjxCwCEzOWI4Ouu7wPG2HpHfUOHDr9BhzQF7aIJbZ8OSUafH2dUR5p02GBCS412BgNNnxh0v6eND_T2ZbbMPgTAgna7pF2iHW61852-JGeN3ka8-rtj8r5cvM3vs9XT3cN8tspMXhUss1rAgMN6bZllFctZIZlgvCqQW6hKbAxamec1ANZGaBTYgCwrYRrBCy75mMCx1wQfY8BG9aHtdNgrBuqgSR01qaMmxdiA3BwRHHZ9txhUNC0Ov9k2oEnK-vZ_-BceyHH0</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Rothman, J.H.</creator><creator>Surriga, O.</creator><creator>Ambrosini, G.</creator><creator>Vasudeva, S.</creator><creator>Schwartz, G.K.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161001</creationdate><title>Suppression of oncogene transcription - PNA as targeted cancer therapy for BRAF-V600E mutant melanoma</title><author>Rothman, J.H. ; Surriga, O. ; Ambrosini, G. ; Vasudeva, S. ; Schwartz, G.K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2741-da606000bbd1d1712149161374e3d075efced922800e8c6ae6ef09576cf634393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rothman, J.H.</creatorcontrib><creatorcontrib>Surriga, O.</creatorcontrib><creatorcontrib>Ambrosini, G.</creatorcontrib><creatorcontrib>Vasudeva, S.</creatorcontrib><creatorcontrib>Schwartz, G.K.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rothman, J.H.</au><au>Surriga, O.</au><au>Ambrosini, G.</au><au>Vasudeva, S.</au><au>Schwartz, G.K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suppression of oncogene transcription - PNA as targeted cancer therapy for BRAF-V600E mutant melanoma</atitle><jtitle>Annals of oncology</jtitle><date>2016-10-01</date><risdate>2016</risdate><volume>27</volume><spage>vi117</spage><epage>vi117</epage><pages>vi117-vi117</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdw368.11</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0923-7534
ispartof	Annals of oncology, 2016-10, Vol.27, p.vi117-vi117
issn	0923-7534 1569-8041
language	eng
recordid	cdi_crossref_primary_10_1093_annonc_mdw368_11
source	EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title	Suppression of oncogene transcription - PNA as targeted cancer therapy for BRAF-V600E mutant melanoma
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T00%3A11%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suppression%20of%20oncogene%20transcription%20-%20PNA%20as%20targeted%20cancer%20therapy%20for%20BRAF-V600E%20mutant%20melanoma&rft.jtitle=Annals%20of%20oncology&rft.au=Rothman,%20J.H.&rft.date=2016-10-01&rft.volume=27&rft.spage=vi117&rft.epage=vi117&rft.pages=vi117-vi117&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdw368.11&rft_dat=%3Celsevier_cross%3ES0923753419439987%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419439987&rfr_iscdi=true